Buy TAGRISSO 40 mg/1 osimertinib

TAGRISSO 40 mg tablets are a prescription medication used in the treatment of certain types of non-small cell lung cancer. This medication contains osimertinib, a targeted therapy designed to inhibit specific mutations in cancer cells. TAGRISSO is manufactured by AstraZeneca Pharmaceuticals LP and is available in a 30-tablet bottle.

Strength

40 mg/1

Pack Size

30 TABLET, FILM COATED in 1 BOTTLE (0310-1248-30)

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

TAGRISSO 40 mg tablets are primarily used for the treatment of non-small cell lung cancer (NSCLC) with specific EGFR mutations. Osimertinib, the active ingredient, works by targeting these mutations to help slow the growth and spread of cancer cells. This medication is often prescribed for patients who have tested positive for these mutations, either initially or after other treatments have been tried. TAGRISSO is designed to be taken orally and is part of a broader treatment plan that may include other therapies.

Side Effects

Common effects of TAGRISSO 40 mg tablets may include diarrhea, rash, and dry skin. Some patients may also experience fatigue, nausea, or decreased appetite. These effects can vary in severity and may not affect everyone who takes the medication. It is important to discuss any persistent or bothersome effects with a healthcare provider.

Precautions & Warnings

TAGRISSO 40 mg tablets should be handled with care and stored as directed. This medication is intended for oral use only and should be taken exactly as prescribed. It is important to inform your healthcare provider about any other medications you are taking, as well as any medical conditions you have. Pregnant women or those planning to become pregnant should discuss the potential risks with their healthcare provider before starting TAGRISSO.

Avoid Interactions

TAGRISSO 40 mg tablets may interact with certain medications, including those that are metabolized by the liver's CYP3A4 enzyme. This can affect how well the medication works or increase the risk of side effects. It is important to avoid grapefruit and grapefruit juice while taking TAGRISSO, as they can interfere with the metabolism of the medication. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.

References

Frequently Asked Questions

TAGRISSO is used to treat non-small cell lung cancer with specific EGFR mutations. It is designed to target these mutations to help slow the growth and spread of cancer cells.

TAGRISSO should be taken orally, exactly as prescribed by your healthcare provider. It is important to follow the dosage and administration instructions provided.

Common side effects of TAGRISSO may include diarrhea, rash, dry skin, fatigue, nausea, and decreased appetite. These effects can vary in severity and may not affect everyone who takes the medication.

TAGRISSO may interact with certain medications, particularly those metabolized by the liver's CYP3A4 enzyme. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

The safety of TAGRISSO during pregnancy has not been established. Pregnant women or those planning to become pregnant should discuss the potential risks with their healthcare provider before starting TAGRISSO.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.